CT 2576
CT 2576 is a phospholipid signaling inhibitor as well as a Jak3/STAT5 inhibitor. CT 2576 suppresses gene expression and replication of human immunodeficiency virus (HIV) at the post-transcriptional level by interfering with phospholipid metabolism in host cells, particularly by inhibiting the production of phosphatidic acid PA. CT-2576 completely inhibits the growth and proliferation of malignant T-cell lymphoma cells by suppressing phospholipid signaling and blocking the Jak/STAT signaling pathway associated with IL-2R. CT 2576 can be used in research related to human immunodeficiency virus (HIV) infection and cutaneous T-cell lymphoma (CTCL).
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 166981-11-9
- 화학식: C26H47N5O3
- 분자량:477.69
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Endogenous Metabolite Isoforms
More
Biological Activity
제품 설명
|
HIV |
STAT5 |
JAK3 |
In Vitro
CT 2576 (2-8 μM; 1 h) inhibits Tat (HY-P0281)-induced phosphatidic acid (PA) accumulation in 293tat cells[1].
CT 2576 (4-32 μM; 24 h) inhibits HIV LTR-mediated gene expression activated by Tat and TNF-α (HY-P704246) in 293tat and 293tat3 human embryonic kidney cells, with an IC50 of 8-10 μM[1].
CT 2576 (for 4 days) inhibits constitutive, TNF-α-induced, and IL-6 (HY-P704644)-induced HIV-1 p24 antigen expression in U1 human promonocytes, with an IC50 of approximately 1 μM[1].
CT 2576 (up to 12.5 μM; 24 h) potently inhibits the proliferation of malignant T-cell lymphoma cell lines PB-1, 2A, 2B and phytohemagglutinin (PHA)-stimulated PBMCs, with an IC50 of 2-3 μM[2].
CT 2576 (2-16 h) inhibits constitutive tyrosine phosphorylation of Jak3 and STAT5 in a time-dependent manner in malignant T cells (PB-1, 2A, 2B)[2].
CT 2576 (8-16 h) inhibits IL-2 (Y-P7037B)-induced Jak3 phosphorylation in IL-2-dependent SZ-4 cells, and partially suppresses constitutive tyrosine phosphorylation of multiple cellular proteins in 2B cells[2].
CT 2576 (12 μM; pretreated for 30 min followed by 18 h of stimulation) has no effect on NF-κB activation or AP mRNA transcription in 293tat cells co-treated with TNF-α or IL-1β (HY-P704378)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 166981-11-9
-
분자량 477.69
-
화학식 C26H47N5O3
-
SMILES
O=C1C2=C(N=CN2C)N(C(=O)N1CCCCCCCCCC(O)CNCCCCCCCC)C
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
RT-PCR
Reverse transcription technology uses RNA as a template to synthesize DNA. RT-PCR is simple, specific and sensitive, and can be used to detect gene expression levels and expression differences in cells; detect RNA virus content; clone cDNA sequences of specific genes.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Real Time qPCR (Q-PCR)
Real-time quantitative PCR (qPCR) quantifies an amplifiable nucleic-acid target by monitoring fluorescence during PCR cycling rather than measuring product only after amplification. The increase in fluorescence tracks accumulation of PCR product, and the quantification cycle (Cq; historically also Ct/CP) is related to the initial amount of target: samples containing more starting target generally reach the defined fluorescence threshold in fewer cycles.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- CT 2576
- 166981-11-9
- CT2576
- CT-2576
- Endogenous Metabolite
- HIV
- Interleukin Related
- JAK
- STAT
- 293tat human embryonic kidney cells
- 2B malignant T-cell lymphoma cells
- 2A malignant T-cell lymphoma cells
- SZ-4 IL-2-dependent cutaneous T-cell lymphoma cells
- cutaneous T-cell lymphoma
- PB-1 malignant T-cell lymphoma cells
- STAT5
- Jak3
- human immunodeficiency virus
- U1 human promonocyte cells
- Inhibitor
- inhibitor
- inhibit